)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
PHC
PHC (6523) investor relations material
PHC Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary11 Nov, 2026
Executive summary
H1 FY2027 revenue was ¥179,970 million, up 3.8% YoY; operating profit rose 87.3% to ¥19,439 million, led by Diabetes Management and Diagnostics & Life Sciences.
Profit attributable to owners of parent was ¥13,313 million versus a ¥559 million loss a year earlier; adjusted EBITDA increased 37.9% to ¥33,466 million.
Full-year forecasts were raised to ¥366,000 million revenue, ¥33,000 million operating profit and ¥18,000 million profit attributable to owners; annual dividend remains ¥42 per share.
Financial highlights
Revenue increased ¥6,600 million YoY; excluding FX impact, revenue was ¥170,700 million, down 1.5%.
Profit before tax was ¥17,007 million versus ¥941 million a year earlier; FX gains were ¥984 million versus ¥6,842 million of FX losses.
Gross profit was ¥87,342 million versus ¥79,594 million; SG&A decreased to ¥68,688 million from ¥70,018 million.
EBITDA was ¥32,666 million, up 37.7%; adjusted EBITDA was ¥33,466 million, up 37.9%.
Operating cash flow was ¥21,184 million, up ¥9,097 million YoY; period-end cash and cash equivalents were ¥37,777 million.
Outlook and guidance
FY2027 revenue forecast rose ¥6,300 million to ¥366,000 million; operating profit forecast rose ¥6,000 million to ¥33,000 million, at a 9% margin.
Profit before tax is forecast at ¥26,700 million and profit attributable to owners at ¥18,000 million; adjusted EBITDA forecast increased to ¥60,900 million.
Revised forecast assumes ¥182/€ and ¥159/US$; H1 Diabetes Management strength and updated FX assumptions supported the upgrades.
Segment revenue forecasts are ¥103,700 million for Diabetes Management, ¥125,200 million for Healthcare Solutions and ¥136,900 million for Diagnostics & Life Sciences.
Annual dividend forecast remains ¥42 per share, split evenly between interim and year-end payments.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from PHC
- Q1 FY26 revenue rose 8.1% and operating profit surged 171%, led by Diabetes Management.6523
Q1 2027 - Record profit and revenue, but FX losses hit net profit; FY2026 targets higher earnings and stable dividends.6523Q4 2026
- FX losses drove a sharp profit drop despite stable revenue and strong BGM growth.6523Q3 2026
- Operating profit up 12.7% YoY despite flat revenue and FX-driven net loss.6523Q2 2026
- Operating profit surged 89.6% year-on-year despite a 1.6% revenue decline.6523Q1 2026
- Operating profit more than doubled year-on-year, with guidance and dividend unchanged.6523Q2 2025
- Q1 revenue and profit grew, but FX losses caused a net loss; full-year guidance unchanged.6523Q1 2025
- FY24 profit surged on cost cuts and M&A, but FY25 profit is forecast to decline on restructuring and tariffs.6523Q4 2025
- Profit and revenue up 4.0% year-over-year, driven by CGM, e-prescriptions, and Pathology.6523Q3 2025
Next PHC earnings date
Q3 202711 Feb, 2027
PHC
Next PHC earnings date
Q3 202711 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
PHC Holdings Corporation is a healthcare technology company specializing in medical devices, diagnostics, and life sciences solutions. The company develops and manufactures products such as blood glucose monitoring systems, insulin delivery devices, biomedical laboratory equipment, and diagnostics for disease management. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange (TSE).